Haloperidol
CAS 52-86-8
Overview
Haloperidol, sold under the brand name Haldol among others, is a typical antipsychotic medication. Haloperidol is used in the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations in alcohol withdrawal
Anant Labs manufacture and furnish high quality Haloperidol impurities for global markets. Our Haloperidol EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS52-86-8
Mol. FormulaC21H23ClFNO2
Mol. Weight375.871 g/mol
IUPAC4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
SMILESC1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
InChIInChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
InChI KeyLNEPOXFFQSENCJ-UHFFFAOYSA-N
Synonyms
haloperidol52-86-8SerenaceAloperidinEukystolSerenaseSerenelfiLintonBrotoponDozicEinalon SAloperidoloGaloperidolHalopoidolHalopalKeselanUlcolindUliolindPernoxSernasSernelAldoBioperidoloSigaperidolPelucesHalostenHaldol Solutab4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-oneHaloperidolumFortunanMcN-JR-1625R-16254-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-oneR 16254-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidineDTXSID40341504-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenoneNSC-170973NSC-615296J6292F8L3DNSC1709734-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-CHEBI:5613DTXCID20141504'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenonegamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenonegamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenoneButyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-VESALIUM COMPONENT HALOPERIDOL4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenonegamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-oneButyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-KentaceKeselenDolpin4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenonegamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidyl)-1-(4-fluorophenyl)-butan-1-oneRefChem:5876N05AD01200-155-6AloperidolHalojustMixidolLealgin compositumAloperidonMDMO-PPV177716-59-5C21H23ClFNO2MFCD00051423Haloperidol (Haldol)CHEMBL54Haldol (TN)4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenoneMLS000028450Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-oneNSC615296CAS-52-86-8NCGC00015500-10Aloperidolo [DCIT]HalidolHalopidolPekucesSMR000058303HalolAloperidolo [Italian]S1920Haloperidolum [INN-Latin]NeurodolNSC 170973CCRIS 1630HSDB 3093SR-01000003076EINECS 200-155-6NSC 615296BRN 0331267DuraperidolUNII-J6292F8L3DFortunan;Haloperidol RSEpoxide resin,Haloperidol CRSEpoxy resin;Haldol;Picroside-IIIDozic;Haloperidol, 1Haloperidol, powderPrestwick_250Haloperidol [USAN:USP:INN:BAN:JAN]PS14 - HaloperidolHaloperidol (Standard)Spectrum_000861Tocris-0931starbld0018801Epoxide resin, E-44Opera_ID_446HALOPERIDOL [MI]4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)Prestwick0_000115Prestwick1_000115Prestwick2_000115Prestwick3_000115Spectrum2_001268Spectrum3_000448Spectrum4_000570Spectrum5_000788HALOPERIDOL [INN]HALOPERIDOL [JAN]Lopac-H-1512HALOPERIDOL [HSDB]HALOPERIDOL [USAN]Biomol-NT_000035GTPL86Probes1_000255Probes2_000296H 1512HALOPERIDOL [VANDF]SCHEMBL8264HALOPERIDOL [MART.]Lopac0_000583Oprea1_509923BSPBio_000130BSPBio_002096HALOPERIDOL [USP-RS]HALOPERIDOL [WHO-DD]HALOPERIDOL [WHO-IP]KBioGR_000980KBioGR_002390KBioSS_001341KBioSS_0023955-21-02-00377 (Beilstein Handbook Reference)MLS001146904BIDD:GT0128DivK1c_000654SPECTRUM1500325SPBio_001236SPBio_0020692-Chloro-4,6-difluorophenlolMcM-JR-1625BPBio1_000144BPBio1_001231orb1311010orb3141230Haloperidol (JP18/USP/INN)Haloperidol - Bio-X trade markBDBM21398Haloperidol, 1mg/ml in MethanolHMS502A16KBio1_000654KBio2_001341KBio2_002390KBio2_003909KBio2_004958KBio2_006477KBio2_007526KBio3_001316KBio3_002869LNEPOXFFQSENCJ-UHFFFAOYSA-HALOPERIDOL [ORANGE BOOK]MSK7134cMAP_000037NINDS_000654AC250GLXC-06536HALOPERIDOL [EP MONOGRAPH]HALOPERIDOL [USP IMPURITY]HMS1568G12HMS1920D03HMS2089M15HMS2091J09HMS2095G12HMS2234P08HMS3261F08HMS3370H11HMS3657I13HMS3712G12HMS5080H05Pharmakon1600-01500325HALOPERIDOL [USP MONOGRAPH]Haloperidol 1.0 mg/ml in MethanolSTR04750L-Threonine-N-fmoc,o-t-butyl etherPTH-L-HISTIDINE HYDROCHLORIDETox21_110162Tox21_300475Tox21_5005834-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenoneCCG-36042CCG-39111EBC-03897HALOPERIDOLUM [WHO-IP LATIN]HY-14538RNSC757054STL417208AKOS000280660Haloperidol for system suitability CRSSamarium(III) acetylacetonate xhydrateTox21_110162_1AT13670CS-1971DB00502FG32041FH23734Haloperidol for peak identification CRSLP00583NSC-757054SDCCGSBI-0050565.P005IDI1_000654MRF-0000027QTL1_000042WLN: T6NTJ A3VR DF& DQ DR DGNCGC00015500-01NCGC00015500-02NCGC00015500-03NCGC00015500-04NCGC00015500-05NCGC00015500-06NCGC00015500-07NCGC00015500-08NCGC00015500-09NCGC00015500-11NCGC00015500-12NCGC00015500-13NCGC00015500-14NCGC00015500-15NCGC00015500-16NCGC00015500-17NCGC00015500-19NCGC00015500-24NCGC00015500-32NCGC00016234-01NCGC00023875-02NCGC00023875-04NCGC00023875-05NCGC00023875-06NCGC00023875-07NCGC00023875-08NCGC00023875-09NCGC00254503-01NCGC00261268-01AC-19691BH166165DA-74000HY-14538SY052276SBI-0050565.P004Haloperidol decanoate impurity, haloperidol-SC 170973AB00052008EU-0100583H0912NS00010402ST50319916SW196557-4C01814D00136H55351M04089VU0239704-10AB00052008-21AB00052008-22AB00052008_23AB00052008_24Haloperidol; Haloperidol Decanoate EP Impurity GL000288Q251347SR-01000003076-2SR-01000003076-8BRD-K67783091-001-04-8BRD-K67783091-001-05-5BRD-K67783091-001-25-3BRD-K67783091-001-26-1BRD-K67783091-003-03-6BRD-K67783091-003-07-7HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY]SR-01000003076-11Z1590789254Haloperidol, European Pharmacopoeia (EP) Reference Standard.gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenoneHALOPERIDOL DECANOATE IMPURITY, HALOPERIDOL- [USP IMPURITY]Haloperidol, United States Pharmacopeia (USP) Reference Standard.gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-oneHaloperidol, Pharmaceutical Secondary Standard; Certified Reference Material4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanoneHaloperidol for peak identification, European Pharmacopoeia (EP) Reference StandardHaloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard65111-47-9InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2Poly[2-methoxy-5-(3 inverted exclamation marka,7 inverted exclamation marka-dimethyloctyloxy)-1,4-phenylenevinylene]